Cargando…

Author Correction: Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway

Detalles Bibliográficos
Autores principales:	Kumar, Sushil, Nandi, Ajeya, Singh, Snahlata, Regulapati, Rohan, Li, Ning, Tobias, John W., Siebel, Christian W., Blanco, Mario Andres, Klein-Szanto, Andres J., Lengner, Christopher, Welm, Alana L., Kang, Yibin, Chakrabarti, Rumela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Author Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262875/ https://www.ncbi.nlm.nih.gov/pubmed/35798701 http://dx.doi.org/10.1038/s41467-022-30946-9

Ejemplares similares

Dll1(+) quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway
por: Kumar, Sushil, et al.
Publicado: (2021)

The many facets of Notch signaling in breast cancer: toward overcoming therapeutic resistance
por: Nandi, Ajeya, et al.
Publicado: (2020)

Consequences of EMT-Driven Changes in the Immune Microenvironment of Breast Cancer and Therapeutic Response of Cancer Cells
por: Singh, Snahlata, et al.
Publicado: (2019)

Estrogen-dependent DLL1-mediated Notch signaling promotes luminal breast cancer
por: Kumar, Sushil, et al.
Publicado: (2018)

Management of Chemoresistant and Quiescent Gestational Trophoblastic Disease
por: Ngu, Siew-Fei, et al.
Publicado: (2014)

RON promotes the metastatic spread of breast carcinomas by subverting antitumor immune responses
por: Eyob, Henok, et al.
Publicado: (2013)

LPCAT2 controls chemoresistance in colorectal cancer
por: Cotte, Alexia Karen, et al.
Publicado: (2018)

Disrupting the endothelin and Wnt relationship to overcome chemoresistance
por: Rosanò, Laura, et al.
Publicado: (2015)

Author Correction: Minimally Invasive Delivery of Microbeads with Encapsulated, Viable and Quiescent Neural Stem Cells to the Adult Subventricular Zone
por: Matta, Rita, et al.
Publicado: (2020)

A post-transcriptional program of chemoresistance by AU-rich elements and TTP in quiescent leukemic cells
por: Lee, Sooncheol, et al.
Publicado: (2020)

Transcriptomic profile of intrinsically chemoresistant acute myeloid leukemia patients
por: Horibata, Sachi
Publicado: (2019)

Divergent functions and distinct localization of the Notch ligands DLL1 and DLL3 in vivo
por: Geffers, Insa, et al.
Publicado: (2007)

Context-Dependent Functional Divergence of the Notch Ligands DLL1 and DLL4 In Vivo
por: Preuße, Kristina, et al.
Publicado: (2015)

MiR-34a-5p promotes multi-chemoresistance of osteosarcoma through down-regulation of the DLL1 gene
por: Pu, Youguang, et al.
Publicado: (2017)

Distinct expression patterns of Notch ligands, Dll1 and Dll4, in normal and inflamed mice intestine
por: Shimizu, Hiromichi, et al.
Publicado: (2014)

Chronic activation of DNA damage signals causes tumor immune evasion in the chemoresistant niche
por: Jinushi, Masahisa
Publicado: (2012)

A perspective on DNA damage-induced potentiation of the pentose phosphate shunt and reductive stress in chemoresistance
por: Milanese, Chiara, et al.
Publicado: (2020)

Survivin-3B promotes chemoresistance and immune escape by inhibiting caspase-8 and -6 in cancer cells
por: Végran, Frédérique, et al.
Publicado: (2013)

Author Correction: Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection
por: Caiado, Francisco, et al.
Publicado: (2019)

Author Correction: Butein promotes ubiquitination-mediated survivin degradation inhibits tumor growth and overcomes chemoresistance
por: Dong, Xin, et al.
Publicado: (2023)

A pre-existing population of ZEB2(+) quiescent cells with stemness and mesenchymal features dictate chemoresistance in colorectal cancer
por: Francescangeli, Federica, et al.
Publicado: (2020)

Author Correction: Hysteresis control of epithelial-mesenchymal transition dynamics conveys a distinct program with enhanced metastatic ability
por: Celià-Terrassa, Toni, et al.
Publicado: (2019)

Inhibition of the mevalonate pathway to override chemoresistance and promote the immunogenic demise of cancer cells: Killing two birds with one stone
por: Riganti, Chiara, et al.
Publicado: (2013)

Normal Development in Mice Over-Expressing the Intracellular Domain of DLL1 Argues against Reverse Signaling by DLL1 In Vivo
por: Redeker, Christian, et al.
Publicado: (2013)

The ectodomains determine ligand function in vivo and selectivity of DLL1 and DLL4 toward NOTCH1 and NOTCH2 in vitro
por: Tveriakhina, Lena, et al.
Publicado: (2018)

DLL3 regulates Notch signaling in small cell lung cancer
por: Kim, Jun W., et al.
Publicado: (2022)

Elf5 inhibits epithelial mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2/Slug
por: Chakrabarti, Rumela, et al.
Publicado: (2012)

AACR Special Conference: Advances in Breast Cancer Research – Genetics, Biology, and Clinical Implications, Huntington Beach, California, USA, 8–12 October 2003
por: Welm, Alana L
Publicado: (2004)

Toward improved models of human cancer
por: Welm, Bryan E., et al.
Publicado: (2021)

Author Correction: PAK1 confers chemoresistance and poor outcome in non-small cell lung cancer via β-catenin-mediated stemness
por: Chen, Ming-Jenn, et al.
Publicado: (2020)

Author Correction: High-resolution Nanopore methylome-maps reveal random hyper-methylation at CpG-poor regions as driver of chemoresistance in leukemias
por: Magi, Alberto, et al.
Publicado: (2023)

Clinical implications of DLL4 expression in gastric cancer
por: Ishigami, Sumiya, et al.
Publicado: (2013)

DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms
por: Yao, James, et al.
Publicado: (2022)

Distinct Cell Stress Responses Induced by ATP Restriction in Quiescent Human Fibroblasts
por: Yalamanchili, Nirupama, et al.
Publicado: (2016)

ΔNp63 promotes stem cell activity in mammary gland development and basal-like breast cancer by enhancing Fzd7 expression and Wnt signaling
por: Chakrabarti, Rumela, et al.
Publicado: (2014)

Differentiated cytoplasmic granule formation in quiescent and non-quiescent cells upon chronological aging
por: Lee, Hsin-Yi, et al.
Publicado: (2016)

Synchronization of endothelial Dll4-Notch dynamics switch blood vessels from branching to expansion
por: Ubezio, Benedetta, et al.
Publicado: (2016)

Therapeutic promise and challenges of targeting DLL4/NOTCH1
por: Yan, Minhong
Publicado: (2011)

DLL3: an emerging target in small cell lung cancer
por: Owen, Dwight H., et al.
Publicado: (2019)

Maintenance of Bone Homeostasis by DLL1‐Mediated Notch Signaling
por: Muguruma, Yukari, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2qbkhe4p2mvfb4m0b2cibarivr